| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 36.09B | 40.24B | 37.06B | 33.73B | 31.88B | 29.50B |
| Gross Profit | 7.07B | 8.07B | 7.26B | 5.89B | 5.37B | 5.56B |
| EBITDA | 4.49B | 3.40B | 4.60B | 3.30B | 2.76B | 3.50B |
| Net Income | 2.97B | 3.38B | 3.05B | 1.91B | 1.64B | 2.14B |
Balance Sheet | ||||||
| Total Assets | 57.62B | 69.00B | 57.24B | 62.08B | 54.98B | 52.12B |
| Cash, Cash Equivalents and Short-Term Investments | 11.74B | 10.30B | 12.75B | 14.39B | 12.46B | 13.07B |
| Total Debt | 3.02B | 1.01B | 920.21M | 1.56B | 1.07B | 986.51M |
| Total Liabilities | 13.38B | 16.27B | 14.16B | 20.48B | 16.78B | 15.19B |
| Stockholders Equity | 43.76B | 52.22B | 42.61B | 41.13B | 37.90B | 36.63B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -5.68B | -596.51M | 2.07B | -37.02M | 501.88M |
| Operating Cash Flow | 0.00 | -3.48B | 897.21M | 2.77B | 649.98M | 972.88M |
| Investing Cash Flow | 0.00 | -3.24B | 36.60M | -121.63M | -757.59M | 561.83M |
| Financing Cash Flow | 0.00 | 4.08B | -2.53B | -790.56M | -519.52M | -823.73M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥43.56B | 14.21 | ― | 3.74% | 4.73% | 17.57% | |
70 Outperform | ¥120.91B | 7.98 | ― | 1.92% | 13.77% | 39.53% | |
68 Neutral | ¥126.02B | 10.46 | 12.89% | 3.40% | 3.44% | -3.09% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
61 Neutral | ¥55.62B | 14.79 | ― | 1.49% | 8.57% | 11.82% | |
56 Neutral | ¥485.02B | 59.52 | 1.44% | 4.80% | 0.40% | 306.91% | |
55 Neutral | ¥100.62B | 40.32 | ― | 3.53% | -3.19% | -4.14% |